Synonyms: 1-[2-[(1R)-2,3-Dihydro-5-(6-methyl-4-pyrimidinyl)-1H-inden-1-yl]-2,7-diazaspiro[3.5]non-7-yl]-2-(2-methylimidazo[2,1-b]thiazol-6-yl)-ethanone; 2-(2-Methylimidazo[2,1-b][1,3]thiazol-6-yl)-1-{2-[(1R)-5-(6-methylpyrimidin-4-yl)-2,3-dihydro-1H-inden-1-yl]-2,7-diazaspiro[3.5]non-7-ylethanone; PF 5190457; PF-5190457
Molecular Formula: C29H32N6OS
Molecular Weight: 512.67
Linear Structural Formula: C29H32N6OS
MDL Number: MFCD28411390
Purity: >=95% (HPLC)
Storage: room temp
Biochem Physiol Actions: PF-05190457 is an orally available, potent and selective ghrelin receptor inverse agonist. PF-05190457 potently increases insulin secretion in glucose-stimulated human islets.
Legal Information: Sold for research purposes under agreement from Pfizer Inc.